GERRESHEIMER AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.5 EUR | +1.31% |
|
+1.62% | +6.52% |
| 04-22 | GERRESHEIMER AG : Buy rating from Barclays | ZD |
| 04-22 | GERRESHEIMER AG : Jefferies remains its Buy rating | ZD |
Chart calendar Gerresheimer AG
a57828d31.qPLJunW8GlyfsuYyPiEBYR7SGf9IRhxqz22ARa8_xPM._sWw3iCLNzbr3a53UWVoA2-CQ8wqM2gfu13lAd98j8L6m4rfIu12L8uE1g~7ba0548294dc1406b8d1b5afeb74d161
Upcoming events on Gerresheimer AG
Past events on Gerresheimer AG
| 22/04/2024 | PDA Parenteral Packaging Conference |
| 22/04/2024 | Korea Pack Exhibition |
| 11/04/2024 09:00 | Q1 2024 Earnings Call |
| 11/04/2024 06:00 | Q1 2024 Earnings Release |
| 10/04/2024 | China International Medical Equipment Fair Conference |
| 24/03/2024 | PDA Meeting |
| 23/03/2024 | Drug Chemical & Associated Technologies Association Conference |
| 28/02/2024 | Asia Pharma Expo |
| 22/02/2024 09:00 | Q4 2023 Earnings Call |
| 22/02/2024 06:00 | Q4 2023 Earnings Release |
| 19/02/2024 | Biologics Manufacturing Conference |
| 05/02/2024 | MD&M West Conference |
| 23/01/2024 | Pharmapack Europe Expo |
| 16/01/2024 | CIBC Western Institutional Investor Conference |
| 08/01/2024 | Pre Filled Syringes and Injectable Drug Devices Europe Conference |
| 05/12/2023 | DDL Conference |
| 20/11/2023 | DZ Bank Equity Conference |
| 15/11/2023 | Roadshow |
| 12/11/2023 | BNP Paribas Exane MidCap Conference |
| 25/10/2023 13:20 | CPHI Barcelona Conference |
Past dividends on Gerresheimer AG
| 07/06/2023 | Annual 1.25 EUR |
| 08/06/2022 | Annual 1.25 EUR |
| 09/06/2021 | Annual 1.25 EUR |
| 24/06/2020 | Annual 1.2 EUR |
| 06/06/2019 | Annual 1.15 EUR |
| 25/04/2018 | Annual 1.1 EUR |
| 26/04/2017 | Annual 1.05 EUR |
| 28/04/2016 | Annual 0.85 EUR |
| 03/05/2015 | 0.75 EUR |
| 01/05/2014 | Annual 0.7 EUR |
Annual results
| Fiscal Period | November | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 1 392 1 422 -2.11% | 1 419 1 422 -0.23% | 1 498 1 492 0.37% | 1 817 1 779 2.13% | 1 990 2 003 -0.63% | 2 131 |
|
EBITDA Million EUR | Released Forecast Spread | 400 411 -2.75% | 310 307 0.91% | 306 315 -2.62% | 354 347 1.93% | 405 407 -0.52% | 443 |
|
EBIT Million EUR | Released Forecast Spread | 124 261 -52.53% | 156 158 -1.14% | 147 168 -12.2% | 169 183 -7.44% | 213 218 -2.26% | 246 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 98,2 235 -58.24% | 135 143 -5.43% | 128 143 -10.64% | 141 155 -8.96% | 167 169 -0.84% | 199 |
|
Net income Million EUR | Released Forecast Spread | 80,8 185 -56.38% | 88,6 98,6 -10.16% | 83,8 99,5 -15.76% | 96,1 103 -6.67% | 116 119 -2.07% | 142 |
|
EPS EUR | Released Forecast Spread | 2,57 6,37 -59.64% | 2,82 3,14 -10.12% | 2,67 3,17 -15.79% | 3,06 3,30 -7.24% | 3,48 3,55 -1.94% | 4,14 |
| Announcement Date | 19/02/20 | 18/02/21 | 17/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | November | 2020 S1 | 2021 S1 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 667 674 -1.04% | 680 679 0.14% | 371 350 5.8% | 445 436 2.04% | 815 805 1.33% | 473 461 2.56% | 529 525 0.7% | 458 449 1.97% | 500 497 0.48% | 957 955 0.25% | 488 490 -0.39% | 545 530 2.87% | 466 464 0.46% | 505 | 526 | 595 |
|
EBITDA Million EUR | Released Forecast Spread | 136 135 0.72% | 62,0 59,7 3.79% | 90,1 87,8 2.62% | 152 153 -0.66% | 90,5 87,5 3.43% | 112 115 -2.35% | 78,0 77,7 0.45% | 107 109 -1.71% | 185 185 -0.05% | 100 101 -1.12% | 119 105 13.51% | 80,9 82,2 -1.58% | 99,4 | 111 | 140 | |
|
EBIT Million EUR | Released Forecast Spread | 58,3 51,1 14.13% | 61,5 63,7 -3.4% | 21,5 18,8 14.41% | 47,3 51,5 -8.17% | 68,8 73,0 -5.75% | 46,3 46,3 -0.06% | 54,2 68,9 -21.28% | 31,0 33,0 -6.01% | 59,7 62,1 -3.92% | 90,7 93,1 -2.6% | 53,6 54,0 -0.64% | 69,1 60,1 14.98% | 31,9 35,7 -10.69% | 49,7 | 60,8 | 88,8 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 42,1 42,5 -0.85% | 57,9 48,1 20.39% | 20,3 24,2 -15.94% | 38,1 | 48,8 | 76,4 | ||||||||||
|
Net income Million EUR | Released Forecast Spread | 33,1 27,2 21.79% | 37,3 40,5 -7.71% | 10,7 9,70 10.65% | 25,2 31,4 -19.88% | 35,9 43,1 -16.72% | 27,3 28,0 -2.35% | 32,9 43,7 -24.66% | 12,0 16,3 -26.08% | 34,4 36,6 -5.92% | 46,5 48,6 -4.36% | 28,0 32,1 -12.69% | 41,6 36,0 15.6% | 13,0 16,4 -20.68% | 28,2 | 36,1 | 56,5 |
|
EPS EUR | Released Forecast Spread | 1,05 0,87 20.69% | 1,19 1,42 -16.2% | 0,34 0,31 9.68% | 0,80 1,03 -22.33% | 1,14 1,37 -16.79% | 0,87 0,89 -2.25% | 1,05 1,55 -32.26% | 0,38 0,46 -17.39% | 1,05 1,08 -2.78% | 1,45 1,44 0.69% | 0,81 0,94 -13.83% | |||||
| Announcement Date | 14/07/20 | 13/07/21 | 07/04/22 | 13/07/22 | 13/07/22 | 12/10/22 | 23/02/23 | 06/04/23 | 06/07/23 | 06/07/23 | 05/10/23 | 22/02/24 | 11/04/24 | - | - | - |
More events
Past sector events for Gerresheimer AG
| 26/04/2024 | BLUE SAIL MEDICAL CO.,LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | BLUE SAIL MEDICAL CO.,LTD.: Q4 2023 Earnings Release |
| 26/04/2024 11:00 | AVANTOR, INC.: Q1 2024 Earnings Release |
| 25/04/2024 | MOTIC (XIAMEN) ELECTRIC GROUP CO.,LTD: Q1 2024 Earnings Release |
| 25/04/2024 | MICRO-TECH (NANJING) CO.,LTD: Q1 2024 Earnings Release |
| 25/04/2024 | SINOCARE INC.: Q4 2023 Earnings Release |
| 25/04/2024 | JAFRON BIOMEDICAL CO.,LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | MICRO-TECH (NANJING) CO.,LTD: Q4 2023 Earnings Release |
| 25/04/2024 | JAFRON BIOMEDICAL CO.,LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | SINOCARE INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GXI Stock
- Calendar Gerresheimer AG
